Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(100.0%)
4Total
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01050244Phase 2Terminated

The Effect of Soy Protein on Neuropathic Pain

Role: lead

NCT01047774Phase 2Terminated

The Effect of Soy Protein on Post- Breast Cancer Surgery Pain

Role: lead

NCT01352013Phase 2Completed

The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms

Role: lead

NCT01520415Phase 2Completed

Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients

Role: lead

All 4 trials loaded